Active Biotech AB (OSTO:ACTI) Days Payable : 0.00 (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Active Biotech AB Days Payable?

Active Biotech AB's average Accounts Payable for the three months ended in Mar. 2024 was kr3.17 Mil. Active Biotech AB's Cost of Goods Sold for the three months ended in Mar. 2024 was kr0.00 Mil.

The historical rank and industry rank for Active Biotech AB's Days Payable or its related term are showing as below:

OSTO:ACTI's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 148.145
* Ranked among companies with meaningful Days Payable only.

Active Biotech AB's Days Payable stayed the same from Mar. 2023 (0.00) to Mar. 2024 (0.00). stayed the same

Active Biotech AB Days Payable Historical Data

The historical data trend for Active Biotech AB's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Active Biotech AB Days Payable Chart

Active Biotech AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

Active Biotech AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Payable	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Active Biotech AB's Days Payable

For the Biotechnology subindustry, Active Biotech AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Active Biotech AB's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Active Biotech AB's Days Payable distribution charts can be found below:

* The bar in red indicates where Active Biotech AB's Days Payable falls into.

Active Biotech AB Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Active Biotech AB's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (3.528	+	3.173)	/	2 )	/	0	*	365
=	3.3505					/	0	*	365
=	N/A

Active Biotech AB's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

	Days Payable (Q: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (3.173	+	0)	/	1 )	/	0	*	365 / 4
=	3.173					/	0	*	365 / 4
=	N/A

Active Biotech AB Days Payable Related Terms

Thank you for viewing the detailed overview of Active Biotech AB's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Active Biotech AB (OSTO:ACTI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Active Biotech AB (OSTO:ACTI) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

BTPC:Germany

Address

Scheelevagen 22, Lund, SWE, 223 63

Website

https://www.activebiotech.com

Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy.

Active Biotech AB (OSTO:ACTI) Headlines

No Headlines